Lipella Pharma (LIPO): Revenue Growth QoQ

Public company logo of lipella.com (LIPO)

The quarterly sales growth rate illustrates revenue dynamics, with the latest figure standing at -11.40. This chart complements the strategy of Lipella Pharmaceuticals (LIPO) to develop targeted drug delivery systems for urology. The company minimizes risks through a diverse oncology pipeline, focusing on untapped market niches with high demand potential upon the successful completion of trials.

LIPO (Lipella) Quarterly Revenue Growth Rate history from 04/28/2023 to 07/19/2025

Lipella Pharmaceuticals, Inc. - analytical breakdowns and key metrics (LIPO)

- stock price and consensus target price:
- money and cash flow information:
Analysis of all company metrics:Lipella Pharmaceuticals - LIPO
Mass-produced product of lipella.com

For Lipella Pharmaceuticals (LIPO), whose resilience is limited by a dependence on a single drug and the risk of clinical trial failure, the pace of capital inflows becomes a critical survival marker. By analyzing this quarterly revenue chart, an investor assesses the speed of business expansion relative to the previous quarter, allowing them to detect stagnation in time and avoid overpaying for the asset at the peak of its short-term acceleration.

Competing companies

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|China SXT Pharmaceuticals, Inc. - Quarterly Revenue Growth|EPRX - Quarterly Revenue Growth|BHST: Quarterly Revenue Growth|Quarterly Revenue Growth Rate eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Quarterly Revenue Growth|Sales Growth QoQ ENTX (Entera Bio)|Revenue Growth QoQ MindWalk (HYFT)|Quarterly Revenue Growth ABVC BioPharma, Inc. (ABVC)|Revenue Growth QoQ Cumberland Corp CPIX|QNTM - Quarterly Sales Growth|FGEN - Revenue Growth QoQ|TELO - Quarterly Revenue Growth|Rani Therapeutics Inc (RANI) - Revenue Growth QoQ|Sales Growth QoQ SNYR|Revenue Growth QoQ Rallybio Corp|Revenue Growth QoQ LEXX|Quarterly Revenue Growth PULM|PTHL: Revenue Dynamics QoQ|Quarterly Revenue Growth APM (Aptorum Group Ltd)|LYRA - Quarterly Sales Growth|Impact BioMedical Inc - Quarterly Revenue Growth|Revenue Dynamics QoQ TNFA|YCBD (cbdmd.com) - Quarterly Sales Growth|painreform.com - Quarterly Revenue Increase|Quarterly Sales Growth CYTO|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)